Hypothermia for Cardioprotection in Patients with St-Elevation Myocardial Infarction: Do Not Give It the Cold Shoulder Yet

• Published in: Journal of clinical medicine Vol. 11; no. 4; p. 1082
• Main Authors: El Farissi, Mohamed, Mast, Thomas P, van de Kar, Mileen R D, Dillen, Daimy M M, Demandt, Jesse P A, Vervaat, Fabienne E, Eerdekens, Rob, Dello, Simon A G, Keulards, Danielle C, Zelis, Jo M, van 't Veer, Marcel, Zimmermann, Frederik M, Pijls, Nico H J, Otterspoor, Luuk C
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.02.2022; MDPI
• Subjects: Cardiac arrhythmia; Cardiomyocytes; Cardiovascular disease; Clinical medicine; Clinical trials; Confidence intervals; Cooling; Heart attacks; Hypothermia; Ischemia; Mortality; Pathophysiology; Phosphorylation; Review; STEMI; hypothermia; myocardial reperfusion injury; acute myocardial infarction; PCI
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11041082

The timely revascularization of an occluded coronary artery is the cornerstone of treatment in patients with ST-elevation myocardial infarction (STEMI). As essential as this treatment is, it can also cause additional damage to cardiomyocytes that were still viable before reperfusion, increasing infarct size. This has been termed "myocardial reperfusion injury". To date, there is still no effective treatment for myocardial reperfusion injury in patients with STEMI. While numerous attempts have been made to overcome this hurdle with various experimental therapies, the common denominator of these therapies is that, although they often work in the preclinical setting, they fail to demonstrate the same results in human trials. Hypothermia is an example of such a therapy. Although promising results were derived from experimental studies, multiple randomized controlled trials failed to do the same. This review includes a discussion of hypothermia as a potential treatment for myocardial reperfusion injury, including lessons learned from previous (negative) trials, advanced techniques and materials in current hypothermic treatment, and the possible future of hypothermia for cardioprotection in patients with STEMI.